SEC 13F Intelligence

Burrage Capital Management LLC / CYTK

Burrage Capital Management LLC’s Cytokinetics Inc Position

Does Burrage Capital Management LLC own Cytokinetics Inc (CYTK)? Not currently — the last reported position was 244.7K shares worth $5M in Q2 2021; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$5M
Q2 2021
Shares
244.7K
% of Portfolio
+4.85%
Quarters Held
6
position exited

Position History CYTK

Reported value by quarter
Q1 ’20: $4MQ1 ’20Q2 ’20: $6MQ2 ’20Q3 ’20: $6MQ3 ’20Q4 ’20: $5MQ4 ’20Q1 ’21: $6MQ1 ’21Q2 ’21: $5MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021244.7K$5M+4.85%
Q1 2021244.7K$6M+4.61%
Q4 2020246.0K$5M+3.90%
Q3 2020264.9K$6M+4.53%
Q2 2020261.5K$6M+4.31%
Q1 2020318.3K$4M+3.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Burrage Capital Management LLC’s full portfolio or all institutional holders of CYTK.